Nachrichten zur Johnson & Johnson Aktie

Milliardenklage in UK: Babypuder von Johnson & Johnson soll krebserregend sein

Der bekannte US-Konzern Johnson & Johnson wird beschuldigt, mit seinem Babypuder schwere Gesundheitsschäden verursacht zu haben. Das Produkt soll krebserregendes…

Johnson & Johnson: Sammel-Klage in Großbritannien wegen krebserregendem Babypuder

2023 wurde das Puder in Großbritannien vom Markt genommen, angeblich soll der enthaltene Talk Krebs verursachen. Mit einer Sammelklage wenden…

Jamison Loads Up on Johnson & Johnson (JNJ) Stock With a 39K Share Purchase

Key PointsJameson Private Wealth Management increased its JNJ position by 39,471 shares, with an estimated trade value of $6.76 million…

Johnson & Johnson faces UK lawsuit over talcum baby powder

A group of around 3,000 people in the UK has filed a legal claim against Johnson & Johnson (NYSE:JNJ), accusing…

Johnson & Johnson Aktie: MedTech-Abspaltung sorgt für Aufsehen - Analysten sehen langfristiges Potenzial!

Charlotte (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von BofA Securities:Die Analysten von BofA Securities stufen die Aktie von Johnson & Johnson…

Johnson & Johnson Aktienanalyse: Citigroup sieht Spin-off als strategischen Meilenstein - Kaufen!

Bad Marienberg (www.aktiencheck.de)???? Johnson und Johnson überzeugt mit starkem Q3 - Citigroup hebt Kursziel auf 215 USD und bleibt bei…

Johnson & Johnson Aktie: Überzeugender Qualitätstitel mit weiterem Aufwärtspotenzial

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von TD Cowen:TD Cowen erhöhe das Kursziel für die Aktie von Johnson &…

Johnson & Johnson’s MedTech spin-off could boost focus, Bank of America says

Bank of America maintained a ‘Neutral’ rating on Johnson & Johnson (NYSE:JNJ) after the company posted third-quarter results slightly above…

Johnson & Johnson: Pharma-Feuerwerk bei J&J! Starke Zahlen, klare Strategie, steigende Margen!

Die neue Berichtsaison startet diese Woche mit dem Bankensektor und einzelnen Unternehmen aus anderen Bereichen. Im Sektor "Healthcare" macht Johnson…

This 2.7%-Yielding Dividend King Remains One of the Healthiest Income Stocks You Can Buy @themotleyfool #stocks $JNJ $^GSPC

Johnson & Johnson has a very healthy financial profile and growth prospects.…

Johnson & Johnson Aktie: Jahresprognose angehoben

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…

J&J to spin off orthopedics business, sees 2026 sales growth of over 5%

Johnson & Johnson on Tuesday said it plans to separate its orthopedics business into a standalone company named DePuy Synthes.…

ROUNDUP: Johnson & Johnson hebt Umsatzziel erneut an - Trennung von Orthopädie

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) setzt sich nach einem überraschend guten…

Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

ROUNDUP: Johnson & Johnson hebt Umsatzziel erneut an - Trennung von Orthopädie

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) setzt sich nach einem überraschend guten dritten Quartal abermals höhere…

Johnson & Johnson hebt Umsatzziel erneut an - Trennung vom Orthopädiegeschäft

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) setzt sich nach einem überraschend guten…

Ihre wichtigsten Termine: Heute im Blickpunkt: Citigroup, Goldman Sachs, JPMorgan sowie Johnson & Johnson

Big Money Move: Investment Manager Buys $6.9 Million Worth of Johnson & Johnson Shares, According to Recent Filing

Key PointsBought 40,238 JNJ shares; estimated $6.89 million trade based on average pricing for Q3 2025Post-trade holding: 103,832 shares valued…

Best Healthcare Stocks To Keep An Eye On

UnitedHealth Group, Johnson & Johnson, and Hims & Hers Health are the three Healthcare stocks to watch today, according…

Q3 Earnings Season Setup Remains Favorable: What to Know

The big banks dominate this weeks reporting docket, but we also have several bellwethers from other sectors reporting, including Johnson…

Johnson & Johnson in talks to acquire Protagonist Therapeutics, WSJ reports

Johnson & Johnson is in discussions to buy Protagonist Therapeutics , the Wall Street Journal reported on Friday, citing people…

Johnson & Johnson in talks to acquire Protagonist Therapeutics, WSJ reports By Reuters

Johnson & Johnson in talks to acquire Protagonist Therapeutics, WSJ reports…

Johnson & Johnson Aktie: Dauerläufer gibt wieder Gas - Chartanalyse

Düsseldorf (www.aktiencheck.de) - Johnson & Johnson-Chartanalyse von HSBC Trinkaus & Burkhardt:Die Analysten von HSBC Trinkaus & Burkhardt nehmen in einer…

Why Johnson & Johnson (JNJ) is Poised to Beat Earnings Estimates Again

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

Goldman Sachs expects another quarter of outperformance from J&J in Q3

Johnson & Johnson (NYSE:JNJ)’s strong year-to-date performance is likely to continue when the healthcare giant reports third quarter earnings on…

Johnson Controls Invests in Accelsius to Advance Data Center Cooling

JCIs multi-million-dollar investment in Accelsius targets next-gen cooling tech to boost data center efficiency amid AI-driven demand.…

Is Johnson Matthey (JMPLY) Stock Outpacing Its Basic Materials Peers This Year?

Here is how Johnson Matthey PLC (JMPLY) and Alamos Gold (AGI) have performed compared to their sector so far this…

Top Analyst Reports for Microsoft, Amazon.com & Johnson & Johnson

Microsoft rides AI and cloud growth, Amazon leans on AWS and Prime, and Johnson & Johnson gains from strong pharma…

Johnson & Johnson Aktie: Neue Bewertung! Das sagt BofA zum Biopharma-Riesen

Charlotte (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von BofA Securities:Die Analysten von BofA Securities haben das Kursziel für Johnson & Johnson…

Johnson & Johnson (JNJ) Rises Higher Than Market: Key Facts

Johnson & Johnson (JNJ) closed the most recent trading day at $188.64, moving +1.43% from the previous trading session.…

Here are Fridays biggest analyst calls: Nvidia, Apple, Broadcom, Tesla, Netflix, Ferrari, Johnson & Johnson, Coinbase and more

Here are Fridays biggest calls on Wall Street.…

Johnson & Johnson is a buy as drug sales continue to improve, Wells Fargo says

The bank upgraded the pharma giant to overweight from equal weight.…

Johnson & Johnson Aktie: Pharma-Upside in Sicht - Upgrade auf "overweight" - Kursziel auf 212 USD erhöht

San Francisco (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Wells Fargo:Larry Biegelsen, Analyst von Wells Fargo, stuft die Aktie von Johnson…

Should You Buy Kenvue Stock After Its 30% Plunge? @themotleyfool #stocks $KVUE $JNJ

There hasnt been much good news lately for this Johnson & Johnson spinoff.…

Johnson & Johnson: Vom Dampfer zum Rennboot - Geringe Volatilität, volle Kraft voraus!

Gesundheitsriese gibt Gas! Rückblick Der weltweit größte Hersteller von Gesundheitsprodukten mit Hauptsitz in New Brunswick ist ein etabliertes Unternehmen mit…

Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing

Johnson & Johnson (JNJ) closed at $179.71 in the latest trading session, marking a +1.11% move from the prior day.…

Johnson Outdoors Announces Cash Dividend

RACINE, Wis., Sept. 26, 2025 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq: JOUT), a leading global innovator of…

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what…

Johnson & Johnson Aktie: Klare Wende in der Einschätzung - Guggenheim Securities rät nun zum Kauf

Bad Marienberg (www.aktiencheck.de) - Johnson & Johnson : Guggenheim Securities hebt Rating auf "buy" – Kursziel 206 USD nach großer…

Take the Zacks Approach to Beat the Market: LendingTree, AutoZone, J&J in Focus

Zacks highlights winners like LendingTree, AutoZone, and Johnson & Johnson as its proven stock-picking strategies continue to shine.…

Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts

Johnson & Johnson (JNJ) reached $174.16 at the closing of the latest trading day, reflecting a -1.72% change compared to…

Johnson Controls: Neutral Stance Maintained Post Q3

…

Johnson & Johnson: Der alte Dampfer liefert ab

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI): Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda

The United States Pharmaceutical Market is projected to reach $979.25 billion by 2033, from $638.86 billion in 2024, at a…

dpa-AFX ProFeed